Device product
CLIA RDTC 12-Panel Cup and CLIA RDTC 12-Panel Cup (w/Adulteration), Item No. CLIA-RDTC-12 These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.
Z-0304-2016
Product summary
- Firm
- Ameditech Inc
- Event
- Event 72471
- Status
- Terminated
- Classification
- Class II
- Quantity
- 7,482 units
- Official record key
device-enforcement:Z-0304-2016
Official wording
Reason: Ameditech is recalling drug abuse tests because they have shown reduced reactivity.
Code information: 142320 143666 143753 144217 144414 144439 144454 144510 144952
Distribution pattern: Worldwide Distribution - US (nationwide) and Internationally to Australia.
Derived failure modes
-
Unknown
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.